Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis.
D000328:Adult; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001792:Blood Platelets; D004155:Diphenhydramine / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006736:Horses / Q000276:immunology; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D037102:Lectins; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D009460:Neurologic Examination; D014374:Tuberculin Test
D000888:Antibodies, Anti-Idiotypic; D000961:Antilymphocyte Serum; D037102:Lectins; D004155:Diphenhydramine; D006854:Hydrocortisone